NAVCO Pharmaceuticals Inc's total assets for Q4 2024 were $951.32K, a decrease of -8.21% from the previous quarter. TSE:NAV total liabilities were $931.44K for the fiscal quarter, a 294.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.